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Alcoholism and other drug addictions are often accompanied by signs of prefrontal 
cortex dysfunction (see Lyvers, 2000, for a review). Although this evidence is strongest for 
alcohol and cocaine, the frontal lobes also appear to be a major site of action of opiates such 
as heroin or morphine (Kuhar, Pert, & Snyder, 1973; Lewis et al., 1981), and opioid 
dependence is associated with changes in frontal cortical alpha-2-adrenoceptor function and 
noradrenaline release (Gabilondo et al., 1994). Brain imaging studies have revealed frontal 
perfusion deficits in opioid addicts undergoing withdrawal (Krystal et al., 1995; Rose et al., 
1996; Van Dyck et al., 1994), consistent with withdrawal-induced hyperactivity of 
noradrenergic output from locus coeruleus (LC), which inhibits the frontal cortex (Redmond 
& Krystal, 1984). Other researchers have observed signs of brain damage in the frontal lobes 
(Garcia-Sevilla et al., 1997; Liu, Matochik, Cadet & London, 1998; Pezawas et al., 1998), 
and neuropsychological indications of frontal lobe dysfunction such as executive cognitive 
deficits, in opiate addicts (Petry et al., 1998; Strang & Gurling, 1989).  
Previous research by Lyvers and colleagues (Lyvers & Maltzman, 1991; Lyvers, 
Maltzman & Miyata, 1994) has shown that the Wisconsin Card Sorting Test (WCST), a 
widely used index of executive cognitive functioning, is surprisingly sensitive to the effects of 
mild psychoactive doses of alcohol or nicotine. Measures of perseveration selectively 
distinguished drug from placebo or withdrawal conditions; perseveration measures are 
consistently elevated in persons who have suffered frontal lobe injury (Robinson, Heaton, 
Lehman, & Stilson, 1980). The present study compared the acute effects of methadone with 
short-term methadone deprivation on WCST performance in methadone-dependent patients 
undergoing methadone maintenance treatment for opiate addiction.  
Method 
Participants 
The research participants were 39 right-handed (18 male and 21 female) out-patients 
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of the Gold Coast District Health Service Methadone Maintenance Clinic. To qualify for 
participation, patients had to be 18-45 years of age (M = 34.1 years) and stabilized on a 25 
mg or more daily dose of methadone hydrochloride (M = 66.9 mg) for at least one month 
prior to the study.  All participants were screened by interview and excluded if they met any 
of the following criteria: average alcohol consumption exceeding 14 alcoholic drinks per 
week; recent and continuing administration of any neurologically active drugs other than 
methadone; prior history of treatment and/or arrest for alcohol or non-opioid illicit drug 
related problems; major medical conditions; lifetime diagnosis of psychiatric illness. All 
subjects were paid $30 for participating.  
Materials  
Severity of Opiate Dependence Questionnaire (SODQ; Sutherland et al., 1986) - 
assesses quantity and pattern of opiate use, physical withdrawal aspects, withdrawal relief 
drug usage, rapidity of reinstatement after a period of abstinence, history of opiate use, 
narrowing of drug repertoire, tolerance, and subjective sense of habit severity.  
Profile of Mood States (POMS; McNair, Lorr, & Droppleman, 1971) - a 65-item self-
report measure yielding scores on six mood scales. The five scales assessing negative mood 
were combined into a unitary construct to form a POMS Distress Index (POMS-DIST; 
Stanton et al.,1998), and the Vigour scale (POMS-VIG) served to assess subjective arousal.  
Wisconsin Card Sorting Test (WCST) – assesses executive-type functions of set 
maintenance, cognitive flexibility, and ability to inhibit prepotent but incorrect responses.  
The computerized version of the WCST (Heaton et al., 1993) was used in the present study. 
Like the manual version, it requires subjects to sort 128 cards on the basis of the color, 
number, and shape of stimuli depicted on them. People with frontal lobe damage tend to 
make perseverative responses (PRs) and errors (PEs) (Robinson et al., 1980) on this test. The 
dual run procedure used in the present study has been shown to increase the sensitivity of the 
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WCST to frontal lobe dysfunction (Stuss et al., 1983) and drug effects (Lyvers & Maltzman, 
1991; Lyvers et al., 1994) and more selectively activates the prefrontal cortex than the 
standard procedure does (Berman et al., 1995; Smith et al., 1997).  In recognition of their 
sensitivity to prefrontal cortex dysfunction (Mountain & Snow, 1993), the crucial WCST 
measures in the present study were the percentages of responses that were PEs (%PE) and 
PRs (%PR), with the percentage of responses that were nonperseverative errors (%NPE) 
serving as a control index of nonspecific cognitive impairment. 
Procedure 
All subjects were tested individually on clinic premises in the same quiet room. They 
were randomly assigned to two experimental groups.  Patients in the early withdrawal group 
(n = 18) were tested prior to receiving their daily dose of methadone, 24 hrs after the last 
methadone dose.  Patients in the recently dosed group (n = 21) were tested 90 min after 
receiving methadone, when drug plasma levels were expected to be high (Ward, Mattick, & 
Hall, 1992). Subjects were asked to refrain from consuming alcohol and any other 
psychoactives, with the exception of tobacco, for 24 hrs prior to the experimental session, and 
to eat nothing for 3 hrs before testing. They were also asked not to smoke for at least 1 hr 
before the session. All sessions commenced between 8.00 am. and 1.00 p.m.    
 Upon arrival at the clinic, subjects attested to their compliance with the above 
requirements in writing prior to testing. They completed the POMS and SODQ, followed by a 
10 min tone detection task during which skin conductance responses were recorded 
(unpublished data). Subjects then performed the computerised version of the WCST in two 
successive runs.  In the first run, the standard instructions were read aloud to participants.  
Following completion of either all six sorting categories or a maximum of 128 sorting trials, 
the WCST was performed again, this time with added instructions that specified the sorting 
criteria. Following completion of both runs, subjects were debriefed, paid and released.  




Prior to all analyses, data were screened to ensure that statistical assumptions of 
normality, linearity and, where applicable, homogeneity of variance-covariance were 
satisfied. All statistical tests were two-tailed. 
Severity of Opioid Dependence 
 Participants’ SODQ scores ranged from 30 to 81 (M = 58.2), indicating substantial 
variation in their degree of opioid dependence. For the entire sample, Pearson product-
moment correlations were calculated between SODQ scores and WCST measures, as well as 
mood as assessed by the POMS. Consistent with predictions, SODQ scores were significantly 
correlated with the crucial second run WCST scores %PE,  r = .38, p < .05, and %PR, r =
.33,  p < .05. The WCST control measure %NPE was not correlated with SODQ.  POMS-
DIST correlated significantly with SODQ,  r = .35, p < .05.
Effects of Methadone Condition on WCST Measures 
 As SODQ scores were significantly correlated with crucial WCST variables, analyses 
of covariance (ANCOVAs), using SODQ score as the covariate, were conducted on the 
WCST measures, with methadone treatment condition (recently dosed, early withdrawal) as 
the between subjects factor. For the second run only, significant group differences were 
indicated on %PE, F(1, 36) = 5.3,  p < .05, and  %PR, F(1, 36) = 6.01, p < .05. Methadone 
patients in early withdrawal scored significantly higher on %PE (M = 8.6) and %PR (M =
9.1) than did patients who had recently taken methadone (%PE, M = 7.5; %PR, M = 7.6). 
There was no group difference on the second run control measure %NPE, F(1, 36) = .03.  
 Discussion 
As expected, severity of opioid dependence as assessed by the SODQ was 
significantly related to crucial second run WCST measures that are specifically sensitive to 
prefrontal cortex dysfunction. Patients with higher SODQ scores (indicating more severe 
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dependence) made relatively more PRs and PEs, and scored higher on the POMs Distress 
Index. These relationships may reflect deleterious effects of chronic opioid abuse on the 
frontal lobes, or possibly premorbid deficits. Further, controlling for severity of dependence, 
methadone patients in early withdrawal exhibited significantly elevated PRs and PEs on the 
second run of the WCST compared to patients who had received their daily methadone dose, 
suggesting a mildly disruptive effect of early withdrawal on frontal lobe functioning.  Groups 
did not significantly differ on the control measure of NPEs on the second run of the WCST, 
further underscoring the apparently selective nature of methadone’s effect on cognition.  In 
contrast to the significant second run group differences, there were no group differences in 
first run WCST performance on any measure, as in previous drug studies cited above.  
The present findings resemble those obtained in Lyvers et al.’s (1994) study of 
nicotine dependent smokers.  Lyvers et al. observed a selective performance deficit (more 
PEs) during nicotine deprivation that was reversed or “normalized” by nicotine intake in 
heavy smokers.  An obvious similarity between the present research and the earlier nicotine 
study is the common use of drug dependent subjects. Further, a growing body of research 
suggests that central opioid peptide and noradrenergic circuitry are crucially involved in the 
expression of abstinence symptomatology during both nicotine and opiate withdrawal (Koob 
& Nestler, 1997). The alpha-2-adrenoceptor agonist clonidine, often used to suppress opiate 
withdrawal symptoms, has also been reported to suppress craving for nicotine in abstinent 
cigarette smokers (Glassman et al., 1988).  LC hyperactivity and resultant excessive 
norepinephrine release appears to underlie most opiate withdrawal symptomatology (Koob & 
Bloom, 1988; Simonato, 1996), and electrical stimulation of the LC in animals inhibits neural 
activity in the prefrontal cortex (Redmond & Krystal, 1984). Perhaps the modest cognitive 
impairing effects of early methadone withdrawal indicated in the present study, and the 
similar effects of acute nicotine deprivation in heavy smokers, both result from similar 
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changes in noradrenergic neurotransmission within the frontal lobes. Chronic drug-induced 
dysfunction of the mesocortical dopamine system is also likely in both types of dependence  
(Di Chiara, 1995; Lyvers, 2000; Vezina et al., 1992). The cognitive processes of the frontal 
cortex are highly sensitive to both dopaminergic and noradrenergic activity (Arnsten, Steere 
& Hunt, 1996). Future work should further examine the impact of opioid dependence and 
withdrawal on various executive cognitive functions mediated by the prefrontal cortex, as 
such changes are likely to contribute to the disordered behaviors characteristic of addictions.  
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